Literature DB >> 2769755

HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex.

E de Vries1, W van Driel, W G Bergsma, A C Arnberg, P C van der Vliet.   

Abstract

Employing an exonuclease III protection assay we detected a protein in crude HeLa nuclear extracts binding, with apparent sequence specificity, to molecular ends of adenovirus type 2 (Ad2) DNA. This protein, designated nuclear factor IV (NFIV), was purified to homogeneity and was shown to be a hetero-dimer of 72,000 and 84,000 Mr. Binding to terminal Ad2 sequences was strongly enhanced by the presence of either of the sequence-specific DNA-binding proteins nuclear factor I and nuclear factor III. These proteins appeared to function as blockades for translocation of NFIV on DNA, thus producing apparent sequence specificity. In the absence of such a blockade, NFIV moved freely, without energy input, on any double-stranded DNA forming a regular DNA-multimeric protein complex as shown by methidiumpropyl EDTA footprinting and electron microscopy. Binding is completely dependent upon the presence of molecular ends. Evidence was obtained for a two-step mechanism in which termini are recognized by NFIV and used as a starting point for subsequent translocation. The possible functions of the protein in adenovirus DNA replication and in cellular processes requiring DNA termini are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769755     DOI: 10.1016/0022-2836(89)90088-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  81 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  DNA end-binding specificity of human Rad50/Mre11 is influenced by ATP.

Authors:  Martijn de Jager; Claire Wyman; Dik C van Gent; Roland Kanaar
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.

Authors:  J J Turchi; K M Henkels; Y Zhou
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

4.  Synapsis of DNA ends by DNA-dependent protein kinase.

Authors:  Lisa G DeFazio; Rachel M Stansel; Jack D Griffith; Gilbert Chu
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

5.  Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus.

Authors:  Ke Li; Lin Wang; Jun Cheng; Yin-Ying Lu; Ling-Xin Zhang; Jin-Song Mu; Yuan Hong; Yan Liu; Hui-Juan Duan; Gang Wang; Li Li; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Biochemical evidence for Ku-independent backup pathways of NHEJ.

Authors:  Huichen Wang; Ange Ronel Perrault; Yoshihiko Takeda; Wei Qin; Hongyan Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

7.  Rad52 and Ku bind to different DNA structures produced early in double-strand break repair.

Authors:  Dejan Ristic; Mauro Modesti; Roland Kanaar; Claire Wyman
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

Review 8.  B-cell epitopes of autoantigenic DNA-binding proteins.

Authors:  C H Chou; M Satoh; J Wang; W H Reeves
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

9.  Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II.

Authors:  A Dvir; S R Peterson; M W Knuth; H Lu; W S Dynan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Saccharomyces cerevisiae Mre11/Rad50/Xrs2 and Ku proteins regulate association of Exo1 and Dna2 with DNA breaks.

Authors:  Eun Yong Shim; Woo-Hyun Chung; Matthew L Nicolette; Yu Zhang; Melody Davis; Zhu Zhu; Tanya T Paull; Grzegorz Ira; Sang Eun Lee
Journal:  EMBO J       Date:  2010-09-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.